Showing results (1811-1820 of 4,604) with videos related to

Sort By:
Pageof 461
Chemmedchem|May 23, 2009
Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?Ulrike Holzgrabe
Chemmedchem|May 28, 2009
Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided designGeorge Kontopidis, Martin J Andrews, Campbell McInnes, et al.
Chemmedchem|May 30, 2009
The XIXth National Meeting on Medicinal Chemistry: Verona, ItalyLivio Brasili, Daniele Donati, Luisa Mosti
Chemmedchem|June 27, 2009
Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesisJohn L Richardson, Isabelle R E Nett, Deuan C Jones, et al.
Chemmedchem|June 27, 2009
Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductaseStephen Patterson, Deuan C Jones, Emma J Shanks, et al.
Chemmedchem|July 1, 2009
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75Laura De Luca, Maria Letizia Barreca, Stefania Ferro, et al.
Chemmedchem|January 27, 2009
Recent approaches to antifungal therapy for invasive mycosesBijoy P Mathew, Mahendra Nath
Chemmedchem|January 29, 2009
Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsyHee-Kyoung Lee, Liuyin Zhang, Misty D Smith, et al.
Chemmedchem|December 23, 2008
Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis inductionMara Dobroschke, Yvonne Geldmacher, Ingo Ott, et al.
Chemmedchem|December 25, 2008
Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeuticsTiffany S Han, Min-Min Zhang, Aleksandra Walewska, et al.
Pageof 461